How to taper and stop Cymbalta (duloxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper and Stop Cymbalta (Duloxetine)

Cymbalta should be tapered gradually over several weeks to months with dose reductions of approximately 10% of the most recent dose at intervals of at least several days to minimize withdrawal symptoms. 1

Understanding Duloxetine Withdrawal

Abrupt discontinuation of Cymbalta can lead to significant withdrawal symptoms including:

  • Anxiety, irritability, and mood changes 1
  • Dizziness and "electric shock-like sensations" 1
  • Sleep disturbances and fatigue 1
  • Headache, sweating, and gastrointestinal symptoms (vomiting, nausea, diarrhea) 1

Recommended Tapering Protocol

Initial Approach

  • Begin with a reduction of approximately 10% of the original dose per week as a reasonable starting point 2
  • For patients on Cymbalta long-term, slower tapers (10% per month or less) may be more appropriate and better tolerated 2
  • Tapering plans should be individualized based on current dose, duration of treatment, and patient response 2

Practical Implementation

  • For standard capsules (20mg, 30mg, 60mg), consider these steps:
    • If on 60mg daily, reduce to 30mg daily for 2 weeks, then 20mg daily for 2 weeks 1
    • For lower doses, consider alternating day dosing in the final stages of tapering 2
    • Do not open, crush, or chew capsules as this affects how the medication works 1

Advanced Tapering Considerations

  • For patients experiencing significant withdrawal symptoms, even slower tapering may be necessary 3
  • Recent evidence suggests hyperbolic tapering (making smaller reductions as the dose gets lower) may be more effective than linear tapering 3, 4
  • Final doses before complete cessation may need to be very small to prevent a large decrease in neurotransmitter effects when stopped 4, 5

Managing Withdrawal Symptoms

  • Withdrawal symptoms typically appear within days of dose reduction and may last 1-3 days per step 2
  • Consider supportive medications to manage specific symptoms:
    • For anxiety or irritability: Short-term use of medications like trazodone 2
    • For sleep disturbances: Sleep hygiene measures; possibly short-term sleep aids 2
    • For gastrointestinal symptoms: Appropriate symptomatic treatments 2

Special Considerations

  • Pause tapering and restart when the patient is ready if withdrawal symptoms become severe 2
  • Successful tapering may require several weeks to months, especially after long-term use 2, 6
  • Consider cognitive-behavioral therapies during tapering, which increase rates of successful discontinuation 2
  • Discuss with patients that withdrawal symptoms are not necessarily a sign that they need to continue the medication long-term 2

Common Pitfalls to Avoid

  • Avoid tapering too quickly, which increases withdrawal risk 2, 3
  • Do not mistake withdrawal symptoms for recurrence of the original condition 2, 3
  • Never stop Cymbalta abruptly as this significantly increases withdrawal risk 1
  • Be aware that protracted withdrawal may occur months after discontinuation, with symptoms including dysphoria, irritability, and insomnia 2

When to Seek Additional Help

  • If severe withdrawal symptoms occur despite slow tapering 1
  • If symptoms of the original condition worsen significantly during tapering 2
  • If new concerning symptoms develop during the tapering process 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.